하이로닉 인터내셔널 웹사이트로 이동합니다.
인터내셔널 웹사이트에는 수출용 제품으로 대한민국에서 허가하지 않은 장비 및 서비스 내용을 포함하고 있습니다. 해당 내용은 대한민국의 의료기기 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC INTL. website.
The Intrrnation Web Site contains equipment and services that are not authorized by the Republic of Korea These contents are not subject to review and regulation of medical devices in Korea.
하이로닉 US 웹사이트로 이동합니다.
US 웹사이트의 내용은 "FDA"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC US website.
The contents of the US web page are about product information of items approved for "FDA". They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.
하이로닉 EU 웹사이트로 이동합니다.
EU 웹사이트의 내용은 "CE MDD 또는 CE MDR"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC EU website.
The contents of the EU(European) web page are about product information of items approved for "CEMDD or CEMDR" in EU countries. They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.
On March 27th, during the AMWC Monaco 2024, HIRONIC proudly hosted a Global Symposium featuring esteemed speakers Dr. Lukas Kofler from Germany and Dr. Andreas Moutsoudis from Greece.
Dr. Lukas Kofler, the Medical Director at the Center for Skin Diseases in Biberach and Vice-President of the German Society for Dermatosurgery, is an expert in dermatology and dermatosurgery. He is renowned for achieving remarkable patient outcomes using our RF total skin solution, SILKRO™ (GENTLO™). At the symposium, Dr. Kofler shared his insights on treating various scar types with RF microneedling technology.
Dr. Andreas Moutsoudis, a Consultant Plastic Surgeon at Aristotle University's Department of Dermatology in Thessaloniki, Greece, and the founder of Moutsoudis Plastic Surgery, has a focus on skin cancer, breast reconstruction, and facial aesthetic surgery. He has been achieving exceptional skin rejuvenation results for his patients by integrating RF microneedling and PLASMA technologies in SILKRO™ (GENTLO™). During the symposium, Dr. Moutsoudis presented the remarkable outcomes of his clinical cases.
HIRONIC extends its heartfelt appreciation to Dr. Kofler and Dr. Moutsoudis for their outstanding contributions to the symposium. We are excited about the prospects of deepening our engagement with global Key Opinion Leaders (KOLs) and further exploring the scientific foundations of the transformative results achieved with HIRONIC's technology.
HIRONIC Press Center
